Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 02, 2022
Jan. 01, 2022
Current assets:    
Cash and cash equivalents $ 33,019 $ 28,540
Restricted cash 39 41
Accounts receivable, net of allowance for credit losses of $1,333 and $1,493 151,350 134,561
Inventories, net 180,290 165,629
Income taxes receivable 1,796 2,762
Other current assets 21,871 20,101
Total current assets 388,365 351,634
Property, plant and equipment, net 170,411 174,210
Deferred income taxes 4,183 2,934
Goodwill 452,654 459,936
Other intangible assets, net 399,946 412,759
Other assets 19,322 13,873
Total assets 1,434,881 1,415,346
Current liabilities:    
Accounts payable 89,117 85,301
Accrued compensation and benefits 18,636 28,595
Other accrued expenses and current liabilities 29,863 28,254
Current portion of long-term non-revolving debt, net 18,141 18,125
Dividends payable 2,924 2,917
Income taxes payable 14,362 6,328
Total current liabilities 173,043 169,520
Revolving line of credit 238,932 242,312
Long-term non-revolving debt, net 179,864 183,897
Deferred income taxes 70,144 71,836
Other noncurrent liabilities 37,262 38,818
Total liabilities 699,245 706,383
Commitments and contingencies
Shareholders' equity:    
Preferred stock, par value $0.001, 2,000 shares authorized, no shares issued or outstanding
Common stock, par value $0.001, 100,000 shares authorized, 32,400 and 32,121 shares issued and outstanding 32 32
Capital in excess of par value 395,873 394,641
Retained earnings 390,831 363,279
Accumulated other comprehensive loss (51,100) (48,989)
Total shareholders' equity 735,636 708,963
Total liabilities and shareholders' equity $ 1,434,881 $ 1,415,346